Labshake search
Citations for Tocris :
101 - 150 of 204 citations for D Fructose U 13C6 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... Both control and CACNA1A+/− networks at DIV49 were treated acutely with 100 µM D-2-amino-5-phosphonovalerate (D-AP5; Tocris, #0106) for 60 min ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2021Quote: ... the NMDA receptor blocker D-AP5 (25 μM; Tocris), and the GABAA receptor blocker picrotoxin (50 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... NMDA (N-Methyl-D-aspartic acid 10μM Tocris Bioscience), siRNAs (Dharmacon/Horizon ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were maintained in 10 μM D-AP5 (Tocris) to ovoid cellular toxicity.
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... containing GIP (D-Ala2) (50 nmol/kg, Tocris #6699) in sterile saline ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with D-serine (30 μM, Tocris Bioscience; 0226) and diluted slightly to give ∼308 mOsm k-1 (33°C ...
-
bioRxiv - Neuroscience 2022Quote: ... 100 μM D-AP5 (Tocris Bioscience, Bristol, United Kingdom), 10 µM nimodipine (Tocris Bioscience) ...
-
bioRxiv - Neuroscience 2022Quote: ... and d-(−)-2-amino-5-phosphonopentanoic acid (APV, Tocris) were added to the ACSF ...
-
bioRxiv - Microbiology 2023Quote: ... The green fluorescent D-amino acid BADA32 (Tocris Bioscience) was added to a final concentration of 0.5 mM and tubes were incubated at 30°C with shaking for 90 min ...
-
bioRxiv - Neuroscience 2022Quote: ... cocaine hydrochloride and D-amphetamine were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 100 µM D-AP5 (Tocris #79055-68-8) to reflect the resting state61 and then depolarized with 50 mM KCl for indicated time points ...
-
bioRxiv - Neuroscience 2024Quote: ... and N-methyl-d-aspartate acid (NMDA, Tocris Bioscience), γ-aminobutyric acid (GABA ...
-
bioRxiv - Neuroscience 2020Quote: ... 100 μM D-APV (Tocris Cat# 0106, HelloBio Cat# HB0225) was used to isolate AMPAR currents for rectification index recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... N-methyl-D-aspartic acid (NMDA, 10 μM; Tocris 0114) or kainic acid (Tocris ...
-
bioRxiv - Neuroscience 2020Quote: ... and D-2-amino-5-phosphonovalerate (APV, 25 µM, Tocris) in order to block synaptic transmission and ensure that the observed events were due to the stimulation only ...
-
bioRxiv - Neuroscience 2020Quote: ... D-turbocurarine chloride (10 μM,Tocris Bioscience, Minneapolis, MN, USA), 18-β glycyrrhetinic acid (50 μM ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (5ng/ml; carrier-free; Tocris R&D Systems), anti-IFNγ antibody (2 ug/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... D-APV (100 µM, Tocris, 0106, CAS: 79055-68-8), or gabazine (25 µM ...
-
bioRxiv - Neuroscience 2024Quote: ... Kainate and N-methyl-D-aspartate acid (NMDA, Tocris Bioscience), Kainate (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2024Quote: ... Transcription was blocked with actinomycin D (ActD, 25 µM; Tocris) ± drug for 30 minutes then slices were metabolically labelled in 35S-Methionine/Cysteine express protein labeling mix (Perkin Elmer ...
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with 5µg/ml of actinomycin D (Tocris #1229). At indicted time point 3 ...
-
bioRxiv - Systems Biology 2021Quote: ... D-2-hydroxyglutarate (D2-HG, 0 to 1.0 mmol/L; Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... and 40 µM D(−)-2-amino-5-phosphonovaleric acid (APV; Tocris) and 50 nM of rat CGRP or vehicle ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (30 ng/ml; carrier-free; Tocris R&D Systems), IL-6 (30 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-23 (50 ng/ml; carrier-free; Tocris R&D Systems), anti-IFNγ antibody (2 ug/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-1β (10 ng/ml; carrier-free; Tocris R&D Systems), IL-23 (50 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-6 (30 ng/ml; carrier-free; Tocris R&D Systems), IL-1β (10 ng/ml ...
-
bioRxiv - Microbiology 2022Quote: ... and 10 μM SB431541 (TGFBR1 inhibitor, Tocris Bioscience, R&D systems).
-
bioRxiv - Neuroscience 2024Quote: ... Chemicals and drugs were obtained from TOCRIS (d-APV, ALX-5407) and Merck| Sigma-Aldrich (ALX-5407 ...
-
bioRxiv - Neuroscience 2023Quote: ... The recording ACSF was supplemented with D-AP5 (50 µM, Tocris), CNQX (15 µM ...
-
bioRxiv - Neuroscience 2022Quote: ... D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105), and BI2536 (Selleckchem #S1109) ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 µM SMAD inhibitor SB-4321542 (R&D Systems/Tocris, 1614), and 10 µM Rock inhibitor Y-27632 (Selleckchem ...
-
bioRxiv - Cell Biology 2024Quote: ... 200 nM dorsomorphin (R&D),100 nM LDN-193189 (LDN; Tocris) and 2 μM XAV-939 (Xav ...
-
bioRxiv - Microbiology 2024Quote: ... and 10 µM SB431541 (TGFBR1 inhibitor, Tocris Bioscience, R&D systems).
-
bioRxiv - Cell Biology 2023Quote: ... the CDBM medium was supplemented with 0.6 U/ml heparin and 3 mM IWP2 (Tocris) for another 3-day incubation with medium refreshed daily ...
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with the actin inhibitor Cytochalasin-D (5 μM, Tocris), the Ezrin Inhibitor NSC668394 (50 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5, Tocris Bioscience) were added to the bath to block glutamatergic currents ...
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Neuroscience 2022Quote: Experiments were performed in standard aCSF modified with 50μM D-AP5 (Tocris) to block NMDA receptor-mediated currents ...
-
bioRxiv - Neuroscience 2024Quote: For the AMPAR desensitization blocker experiments 50 μM D-APV (Tocris, #0106) and 200 μM CX546 (Tocris ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [d-Ala2,MePhe4,Gly (ol)5]enkephalin (DAMGO) was purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-2-amino-5-posphonopentanoic acid (APV, 100 μM; Tocris, US) at a holding potential−70 mV (n = 12).
-
bioRxiv - Cell Biology 2024Quote: ... DM+D was composed of DM including DAPT (10 µM, Tocris #2634). DM+D+P was composed of DM+D including PD0325901 (0.1 µM ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50 µM 2-amino-5-phosphonopentanoic acid (D-AP5, Tocris Bioscience) were present in the extracellular solutions to isolate spontaneous IPSCs ...
-
bioRxiv - Biochemistry 2024Quote: ... and degradation of endogenous CENP-U-FKBPF36Vwas achieved by addition of 500 nM dTAGV-1 (Tocris). Cells were synchronized using S-trityl-L-cysteine (STLC ...
-
bioRxiv - Neuroscience 2020Quote: Antagonists were bath applied at the following concentrations: D-APV (Tocris Bioscience, 50μM), NBQX (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... currents were pharmacologically isolated by bath application of 50 µM D-APV (Tocris) and 50 µM CNQX (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and currents were pharmacologically isolated by bath application of 50μM D-APV (Tocris), 10 μM CNQX (Sigma) ...